TuesdayMar 10, 2026 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Marks Key Federal Milestone for RapidSX Platform

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Submission of report completes phase 1 of Ucore’s contract with the U.S. Department of Defense to demonstrate the technical capabilities of its RapidSX rare earth separation platform. The DoD has identified rare earth processing as a strategic priority under its industrial base strengthening initiatives. RapidSX combines aspects of conventional solvent extraction with modern column-based design to enable faster throughput, reduced footprint and potentially lower capital and operating costs. Submitting a final technical report to a federal partner is more than a procedural step;…

Continue Reading

TuesdayMar 10, 2026 9:45 am

Unlocking Alaska’s Critical Corridor: How Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Is Well Positioned in America’s Future Mineral Supply Chain

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising. The Department of the Interior’s decision to open 2.1 million acres in Alaska’s Dalton Corridor clears a path for expanded mining access tied to the Ambler Road. Trilogy Metals holds a 50% interest in Ambler Metals, which owns 100% of the Upper Kobuk Mineral Projects spanning 190,929 hectares in the Ambler Mining District. The Arctic deposit hosts 46.7 million tonnes of probable mineral reserves grading 2.11% copper, alongside zinc, lead, gold and silver credits, positioning it among the highest-grade copper projects globally. The…

Continue Reading

TuesdayMar 10, 2026 9:16 am

QualityStocksNewsBreaks – Frontieras North America to Host Groundbreaking for West Virginia Commercial Facility 

Frontieras North America, an energy and environmental technology company commercializing its patented FASForm(TM) Solid Carbon Fractionation process, announced it will host a groundbreaking ceremony on April 2, 2026, for its first commercial facility in Mason County, West Virginia. The estimated $850 million industrial project is expected to create approximately 300 full-time jobs with wages averaging three times the area’s average income, along with about 2,000 construction jobs during the build phase. The ceremony, scheduled for 11:30 a.m. ET, will include remarks from company leadership and federal and state officials, followed by a ceremonial groundbreaking. The company’s FASForm(TM) technology is designed to convert coal…

Continue Reading

TuesdayMar 10, 2026 9:00 am

QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Adopts Shareholder Rights Plan 

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.  MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) has adopted a Shareholder Rights Plan and entered into a Shareholder Rights Plan Agreement with TMX Trust Company as rights agent, effective immediately. The plan, which is consistent with similar measures adopted by Canadian public companies and was not implemented in response to any specific takeover proposal, is designed to provide the company’s board and shareholders adequate time to evaluate any unsolicited takeover bid, explore value-enhancing alternatives and ensure shareholders receive full and fair value. The plan will be subject to…

Continue Reading

TuesdayMar 10, 2026 9:00 am

Beeline Holdings Inc. (NASDAQ: BLNE) Sets March 30 Call to Review Q4 Results, Including a $100M Run Rate by December 2027

Beeline Holdings will host a stakeholder call on March 30 to discuss Q4 2025 financial results and operational updates. The company reported quarterly double-digit revenue growth in 2025 and ended the year with over $50 million in Balance Sheet  equity and no corporate debt. Beeline is scaling an AI-driven mortgage platform designed to shorten closing times and lower origination costs, and is expanding core mortgage, title, and home equity offerings heading into 2026. The company is positioning its products for millennials, gig-economy workers, and real estate investors, and recently introduced a blockchain-enabled home equity product, building SaaS revenue channels. Beeline…

Continue Reading

MondayMar 09, 2026 12:00 pm

Building a New Cancer Care Ecosystem: Liora’s Proton Therapy and LIXTE’s Drug Pipeline in Synergy

LIXTE Biotechnology Holdings and the company’s subsidiary, Liora Technologies, both develop products that aim to improve outcomes for cancer patients Specifically, Liora’s Linac for Image Guided Hadron Therapy (“LiGHT”) System and LIXTE’s LB-100 work together to fight cancer As a result, the companies are building a new cancer care ecosystem that hopes to boost the effectiveness of treatments, while also help them be more accessible for a wider range of patients Recently, LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company, acquired Liora Technologies, a company that is aiming to transform cancer care with innovative compact proton therapy. Specifically,…

Continue Reading

MondayMar 09, 2026 11:15 am

Renewal Fuels Inc. (RNWF) Expands Leadership and Targets 2026 Milestone for Texatron(TM) Fusion Platform

Appointment of fusion researcher Fabrice David adds scientific oversight as commercialization plans advance. Travis Yakimishyn joins as Chief Electrical & Power Systems Officer to lead utility-scale integration. The company is transitioning to American Fusion Inc. following its merger with Kepler Fusion Technologies, with filing and audits nearing completion as the company prepares for SEC reporting status. Management reiterates goal of deploying a 100-megawatt operational unit by year-end 2026, with Kepler‘s plan to sell electricity on a per-kilowatt basis to utilities and industrial customers. Renewal Fuels (OTC: RNWF) (d/b/a American Fusion), an advanced energy platform company focused on the development and…

Continue Reading

MondayMar 09, 2026 10:30 am

Soligenix Inc. (NASDAQ: SNGX) Secures Key European Milestone for Dusquetide Development

“The EMA's positive opinion signifies an important step for Soligenix as we continue to advance the program,” says company CEO. The designation provides incentives that may include protocol assistance, reduced regulatory fees and up to 10 years of market exclusivity following approval. Dusquetide is classified as an innate defense regulator, a type of compound designed to modulate the body’s innate immune system rather than suppress it outright. For patients living with rare inflammatory diseases, regulatory milestones can mark the difference between stalled research and meaningful therapeutic progress. A positive opinion from the European Medicines Agency (EMA) not only validates a…

Continue Reading

MondayMar 09, 2026 9:45 am

HeartBeam Inc. (NASDAQ: BEAT) Moves Forward Focused on Advancing Portable, High-Fidelity Cardiac Monitoring

The company’s core innovation, the HeartBeam System, is positioned as the first cable-free, high-fidelity ECG system capable of capturing the heart’s electrical signals from three distinct directions. HeartBeam’s strategy is built around addressing a long-standing gap in cardiac care. Looking forward, HeartBeam is focused on advancing both its hardware and software platforms. HeartBeam (NASDAQ: BEAT) stands at a pivotal point in its development as a medical technology company focused on transforming how cardiac arrhythmias are detected, evaluated and monitored. Headquartered in Santa Clara, California, HeartBeam is building a platform designed starting with its FDA-cleared synthesized 12-lead ECG system to bring…

Continue Reading

MondayMar 09, 2026 9:22 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences 

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing advanced cardiac insights, announced that its management team will attend several investor and industry conferences in March 2026. CEO Robert Eno and CFO Timothy Cruickshank will participate in the virtual Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 16-17, including a webcast presentation on March 16, while also meeting with institutional and retail investors. The executives will also attend the 38th Annual ROTH Conference in Dana Point, California, on March 23-24, where Eno will join a panel on technologies advancing healthy aging. In addition, Eno, Founder and President Dr. Branislav Vajdic and…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered